Safety and efficacy of zodasiran, a hepatic sirna targeting angptl3, in mixed hyperlipidemia patients: 2 year open label extension (OLE) results from ARCHES-2
用户EMtIfkjv0BaE
1天前
8
10
已关闭
DOI:
文献链接:
其他信息:
RS Rosenson, D Gaudet, RA Hegele…
European Heart …, 2025
academic.oup.com
34 天前 - … Angiopoietin-like protein 3 (ANGPTL3) regulates lipoprotein metabolism in both
the … Naturally-occuring ANGPTL3 loss-of-function variant carriers have lower levels of LDL-…

